CymitQuimica logo

CAS 489415-96-5

:

Formula:C31H33N3O5
InChI:InChI=1S/C31H33N3O5/c1-22-20-25(8-9-26(22)39-21-23-6-3-2-4-7-23)29(35)27-28(24-10-12-32-13-11-24)34(31(37)30(27)36)15-5-14-33-16-18-38-19-17-33/h2-4,6-13,20,28,35H,5,14-19,21H2,1H3/b29-27-/t28-/m0/s1
InChI key:VVYIXKBHQQSREP-SUUDBTLLSA-N
SMILES:CC1=C(C=CC(=C1)/C(=C/2\[C@@H](N(C(=O)C2=O)CCCN3CCOCC3)C4=CC=NC=C4)/O)OCC5=CC=CC=C5
Found 6 products.
  • SBC-115076

    CAS:
    SBC-115076
    Formula:C31H33N3O5
    Purity:99%
    Molecular weight:527.61

    Ref: 54-BUP07855

    5mg
    118.00€
    10mg
    154.00€
    25mg
    264.00€
    50mg
    467.00€
    100mg
    708.00€
    500mg
    1,427.00€
  • SBC-115076

    CAS:
    Formula:C31H33N3O5
    Purity:99%
    Color and Shape:Solid
    Molecular weight:527.6108

    Ref: IN-DA00DB96

    250mg
    To inquire
    25mg
    194.00€
    50mg
    278.00€
    100mg
    621.00€
  • SBC-115076

    CAS:
    SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.
    Formula:C31H33N3O5
    Purity:97.07% - 99.89%
    Color and Shape:Solid
    Molecular weight:527.6108

    Ref: TM-T2626

    1mg
    38.00€
    2mg
    54.00€
    5mg
    79.00€
    1mL*10mM (DMSO)
    86.00€
    10mg
    103.00€
    25mg
    177.00€
    50mg
    308.00€
    100mg
    477.00€
    500mg
    1,062.00€
  • 4-(4-(Benzyloxy)-3-methylbenzoyl)-3-hydroxy-1-(3-morpholinopropyl)-5-(pyridin-4-yl)-1,5-dihydro-2H-pyrrol-2-one

    CAS:
    4-(4-(Benzyloxy)-3-methylbenzoyl)-3-hydroxy-1-(3-morpholinopropyl)-5-(pyridin-4-yl)-1,5-dihydro-2H-pyrrol-2-one
    Formula:C31H33N3O5
    Purity:99%
    Molecular weight:527.61

    Ref: IN-DG630730

    25mg
    185.00€
    50mg
    316.00€
    100mg
    503.00€
    250mg
    821.00€
  • SBC-115,076

    Controlled Product
    CAS:
    Formula:C31H33N3O5
    Color and Shape:Neat
    Molecular weight:527.61

    Ref: TR-S155000

    250mg
    3,174.00€
  • SBC-115076

    CAS:
    SBC-115076 is a monoclonal antibody that binds to the tumor necrosis factor-α (TNF-α) receptor and blocks TNF-α signaling. This drug has been shown to be effective in treating cardiac disease, malignant brain tumors, and atherosclerotic cardiovascular disease. The SBC-115076 antibody is activated by TNF-α, which is released from cells of the immune system or cancer cells. The SBC-115076 antibody prevents TNF-α from binding to its receptor on the surface of other cells and thus prevents activation of those cells. This drug has also been shown to be effective in inhibiting growth of cultured cells, such as cancer cells.
    Formula:C31H33N3O5
    Purity:Min. 95%
    Molecular weight:527.61 g/mol

    Ref: 3D-PUA41596

    25mg
    875.00€
    50mg
    1,320.00€
    100mg
    2,058.00€